Clinical Trial Update: Recurrent Urinary Tract Infections and Heparin (RUTIH Trial) [EARLY_Phase 1]

View source ↗

Summary

The EARLY_Phase 1 Recurrent Urinary Tract Infections and Heparin trial (RUTIH) has completed its phase 1 evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University of Oklahoma | Conditions: Recurrent Urinary Tract Infections | EARLY_Phase 1 | Status: COMPLETED